4.6 Review

Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 21, Issue 7, Pages 419-427

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2010.02.007

Keywords

-

Funding

  1. Medical Research Council [G0701307] Funding Source: researchfish
  2. MRC [G0701307] Funding Source: UKRI
  3. Medical Research Council [G0701307] Funding Source: Medline

Ask authors/readers for more resources

Familial pituitary adenomas can occur in MEN1 and Carney complex, as well as in the recently characterized familial isolated pituitary adenoma (FIPA) syndrome. FIPA is an autosomal dominant disease with incomplete penetrance, characterized by early-onset disease, often aggressive tumor growth and a predominance of somatotroph and lactotroph adenomas. In 20% of FIPA families, heterozygous mutations have been described in the aryl hydrocarbon receptor interacting (AIP) gene, whereas in other families the causative gene(s) are unknown. It has been suggested that AIP is a tumor suppressor gene and although experimental data support this hypothesis, the exact molecular mechanism by which its disruption leads to tumorigenesis is unclear. Here we discuss the clinical, genetic and molecular features of patients with FIPA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available